Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lincoln National Corp bought a new position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the fourth quarter, Holdings Channel reports. The institutional investor bought 5,359 shares of the medical research company’s stock, valued at approximately $265,000. A number of other hedge funds also recently bought and sold shares of the company. Vanguard Group […]
Swiss National Bank reduced its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 5.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 719,180 shares of the medical research company’s stock after selling 43,237 shares during the period. Swiss National Bank owned […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective increased by Bank of America from $80.00 to $88.00 in a research note published on Wednesday, The Fly reports. EXAS has been the subject of several other reports. Raymond James downgraded shares of Exact Sciences from an outperform rating to a market perform rating in […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price hoisted by equities research analysts at Citigroup from $90.00 to $100.00 in a report issued on Thursday, The Fly reports. Citigroup’s target price would suggest a potential upside of 27.02% from the company’s previous close. Several other brokerages have also weighed in on EXAS. StockNews.com […]
Biondo Investment Advisors LLC trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 102,764 shares of the medical research company’s stock after selling 11,686 shares during […]